Uranium Royalty Corp. (UROY) 6-K adds interim financials to Form F-10

Rhea-AI Filing Summary

Uranium Royalty Corp. submitted a Form 6-K as a foreign private issuer for September 2025. The report primarily furnishes supporting documents rather than detailing results in the body of the form.

The filing incorporates Exhibits 99.1 through 99.4 by reference into the company’s Form F-10 registration statement. These exhibits include condensed interim consolidated financial statements and management’s discussion and analysis for the three months ended July 31, 2025, along with officer certifications.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
UNDER the Securities Exchange Act of 1934

For the month of September 2025
Commission File No.: 001-40359

Uranium Royalty Corp.
(Translation of registrant’s name into English)

Suite 1830, 1188 West Georgia Street

Vancouver, British Columbia, V6E 4A2, Canada
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐ Form 40-F ☒

iNCORPORATION bY rEFERENCE

Exhibits 99.1 through 99.4 contained in this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-10, as amended (Registration No. 333-272534) of Uranium Royalty Corp. (including any prospectuses forming a part of such registration statement) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Uranium Royalty Corp.
Date: September 11, 2025	By:	/s/ Andy Marshall
	Name:	Andy Marshall
	Title:	Chief Financial Officer

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		Condensed interim consolidated financial statements for the three months ended July 31, 2025
99.2		Management’s discussion and analysis for the three months ended July 31, 2025
99.3		Certification of Chief Executive Officer

99.4 Certification of Chief Financial Officer

FAQ

What does Uranium Royalty Corp. (UROY) report in this September 2025 Form 6-K?

The Form 6-K furnishes supporting documents rather than detailed results. It includes interim financial statements, management’s discussion and analysis, and officer certifications for the three months ended July 31, 2025.

Which financial statements does Uranium Royalty Corp. (UROY) provide in this filing?

The filing provides condensed interim consolidated financial statements. These cover Uranium Royalty Corp.’s financial position and performance for the three months ended July 31, 2025, offering a snapshot between full annual reporting periods.

What period does Uranium Royalty Corp.’s (UROY) MD&A in Exhibit 99.2 cover?

The management’s discussion and analysis in Exhibit 99.2 covers the three months ended July 31, 2025. It is intended to explain and contextualize the interim financial statements furnished in Exhibit 99.1 for that same period.

How is this Uranium Royalty Corp. (UROY) Form 6-K linked to its Form F-10?

Exhibits 99.1 through 99.4 are incorporated by reference into Uranium Royalty Corp.’s Form F-10 registration statement. This means those exhibits legally form part of the Form F-10 from the date this report is filed.

Who signed Uranium Royalty Corp.’s (UROY) September 2025 Form 6-K?

The Form 6-K was signed on behalf of Uranium Royalty Corp. by Andy Marshall. He is identified in the document as the company’s Chief Financial Officer, acting as an authorized signatory for the registrant.

Which officer certifications accompany Uranium Royalty Corp.’s (UROY) Form 6-K?

Among the exhibits is a certification of the Chief Executive Officer listed as Exhibit 99.3. Additional certifications may be included within Exhibits 99.1 to 99.4, which are incorporated by reference into the Form F-10 registration statement.